J. M. Giaconia

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

S. Schwartz, M. Resnick, T. P. Pretlow, 1996, Cancer research.

Prostate cancer and other xenografts from cells in peripheral blood of patients.

S. Schwartz, C. Connell, M. Resnick, 2000, Cancer research.

Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors

S. Schwartz, T. P. Pretlow, T. Pretlow, 1999, The Prostate.

An essential role for CCL3 in the development of collagen antibody-induced arthritis.

S. Chintalacharuvu, C. Venkataraman, J. M. Giaconia, 2005, Immunology letters.

Xenografts of primary human prostatic carcinoma.

M. Resnick, T. P. Pretlow, E. Kursh, 1993, Journal of the National Cancer Institute.

A new human prostate carcinoma cell line, 22Rv1

S. Schwartz, T. P. Pretlow, J. Rhim, 1999, In Vitro Cellular & Developmental Biology - Animal.

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

S. Schwartz, M. Resnick, T. P. Pretlow, 1994, Cancer research.

Prostate Cancer and Other Xenografts from Cells in Peripheral Blood of Patients 1

S. Schwartz, C. Connell, M. Resnick, 2000 .